SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-175095
Filing Date
2023-06-26
Accepted
2023-06-26 16:14:04
Documents
18
Period of Report
2023-06-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d472315d8k.htm   iXBRL 8-K 31650
2 EX-1.1 d472315dex11.htm EX-1.1 160536
3 EX-5.1 d472315dex51.htm EX-5.1 7780
4 EX-99.1 d472315dex991.htm EX-99.1 5199
5 EX-99.2 d472315dex992.htm EX-99.2 5331
9 GRAPHIC g472315dsp51.jpg GRAPHIC 4375
10 GRAPHIC g472315g0621192450094.jpg GRAPHIC 2747
  Complete submission text file 0001193125-23-175095.txt   398185

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA alvr-20230621.xsd EX-101.SCH 2851
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE alvr-20230621_lab.xml EX-101.LAB 17979
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alvr-20230621_pre.xml EX-101.PRE 11259
12 EXTRACTED XBRL INSTANCE DOCUMENT d472315d8k_htm.xml XML 3334
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 (617) 433-2605
Allovir, Inc. (Filer) CIK: 0001754068 (see all company filings)

IRS No.: 831971007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39409 | Film No.: 231042513
SIC: 2836 Biological Products, (No Diagnostic Substances)